Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Editorial: Women in experiment...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Editorial: Women in experimental pharmacology and drug discovery: 2021

Editorial: Women in experimental pharmacology and drug discovery: 2021

Bibliographic Details
Main Authors: Tea Lanišnik Rižner, Csilla Özvegy-Laczka
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pharmacology
Subjects:
chemerin
osteoprotegerin
osteoporosis
Nrf2
premature ovarian failure
SLCO4A1
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1077670/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1077670/full

Similar Items

  • The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers
    by: Tea Lanišnik Rižner, et al.
    Published: (2017-06-01)
  • Role of Serum Osteoprotegerin as a Diagnostic Indicator of Primary Osteoporosis in Perimenopausal and Postmenopausal Women: An Indian Perspective
    by: Pandey A, et al.
    Published: (2018-03-01)
  • Editorial: Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery
    by: Tea Lanišnik Rižner
    Published: (2019-03-01)
  • Pathogenetic and diagnostic role of osteoprotegerin in the combined course of osteoarthritis and obesity
    by: A. Litvynova, et al.
    Published: (2022-05-01)
  • Nrf2 Signaling Pathway Mediates the Protective Effects of Daphnetin Against D-Galactose Induced-Premature Ovarian Failure
    by: Mengwen Zhang, et al.
    Published: (2022-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs